Italy on Tuesday declared the Johnson & Johnson coronavirus vaccine to be "safe" and said it would prioritise its use for people over 60. The announcement came hours after the European Medicines Agency (EMA) said blood clots should be listed as a "very rare" side effect of the vaccine.

Italy approves J&J vaccine, recommends it for over 60s

The Indian government on Wednesday said 0.03 per cent of people tested positive for coronavirus after taking the second dose of Covishield, while 0.04 per cent contracted the virus after receiving the second jab of Covaxin.

0.03% contracted Covid-19 after receiving second jab of Covishield; 0.04% post Covaxin

Bharat BioTech on Wednesday claimed that its coronavirus vaccine Covaxin has an efficacy of 78 per cent against mild, moderate and severe cases of Covid-19, according to the Phase 3 interim analysis results.

Covaxin has an efficacy of 78% against severe Covid-19 cases: Bharat BioTech

Amid a devastating second wave, India has decided to open vaccinations to all adults. But, how can India and the world crush this surge? WION's Palki Sharma tells you how some countries managed to beat the Wuhan virus.

Gravitas: India opens Wuhan virus vaccinations to all adults

According to the reports, EU Commission has decided not to renew COVID-19 vaccine contracts next year with AstraZeneca and Johnson & Johnson (J&J).

Report: EU to end AstraZeneca and J&J vaccine contracts at expiry

Covid-19 leads to a risk of rare blood clots that’s higher than that of current vaccines, said scientists of the University of Oxford amid concerns that the jabs may be to blame for the potentially deadly condition.

Rare blood clot risk higher from coronavirus than vaccine, says UK study

With many states reporting a shortage of vaccines, the Indian government has decided to fast-track foreign-made jabs. How long before they reach India? Do foreign jabs hold the key to India's vaccination drive? WION's Palki Sharma tells you more.

Gravitas: India's evolving vaccine strategy

Canadian health authority on Tuesday reported the nation's first blood clotting case related to the Oxford-AstraZeneca jab. Health Canada said a Quebec woman who had received the coronavirus vaccine prepared by the Serum Institute of India was Canada's first case of blood clotting with low platelets.

Canada reports first blood clot case linked to AstraZeneca vaccine

As fresh infections surge, India has decided to fast track approvals for foreign vaccines. What does this mean? How soon can Indians get more shots? WION's Palki Sharma tells you all that you need to know - with 10 questions and answers.

Gravitas: India fast-tracks approvals for foreign vaccines

Denmark on Tuesday banned the use of Oxford-AstraZeneca coronavirus vaccine, becoming the first European nation to take such action over rare but serious suspected health risks.

Denmark becomes first European nation to stop using AstraZeneca vaccine

France's health body have said that the country will soon issue an advisory that those under the age of 55 who got their first dose of the AstraZeneca COVID-19 vaccine should now get a second shot of an mRNA vaccine.

France health body to issue new advisory on use of AstraZeneca COVID-19 vaccine

Australia has halted the use of the AstraZeneca COVID-19 vaccine for younger people over blood clots concerns. Officials said the AstraZeneca shot should no longer be given to people under the age of 50, unless they had already received a first dose without any ill effects.

Australia halts AstraZeneca COVID-19 vaccine for under 50s

Portugal has restricted the use of the AstraZeneca COVID-19 vaccine to people above the age of 60. Country's coordinator of the national task force for vaccination against COVID-19 Henrique Gouveia e Melo, said that this will have a "small impact," on the vaccination rollout plans.

Portugal restricts the use of AstraZeneca COVID-19 vaccine

Taiwan has praised India for helping Paraguay to get COVID-19 vaccines despite Chinese pressure. Last month India had gifted 100,000 doses of its indigenous vaccine to Paraguay.

Taiwan praises India for helping Paraguay amid Chinese pressure

US President Joe Biden has moved up the COVID-19 vaccine eligibility target for all American to April 19. All states within United States have been directed to widen the vaccine eligibility to people who are 18 and above.

Biden: All Americans to be eligible for COVID-19 vaccines by April 19

The EU drug regulator has said that it is still deciding on whether the AstraZeneca Coronavirus vaccine is actually causing blood clots. The European Medicine Agency (EMA) safety committee has said that it has not yet reached at any conclusion and the review is still ongoing.

EMA: Has not yet reached a conclusion on AstraZeneca COVID-19 vaccine

With no COVID-19 vaccines to offer its 11 million people, the Caribbean nation of Haiti is struggling hard to contain the Coronavirus crisis. So far, Haiti was supposed to receive 756,000 doses of the AstraZeneca vaccine through a United Nations program aimed at ensuring the neediest countries get COVID-19 shots.

Haiti awaits COVID-19 vaccines amid unrest

Amitabh Bachchan is known to keep his fans updated about his day-to-day activities. On Friday, the Bollywood superstar blogged to inform that he had been administered the COVID-19 vaccine.

Amitabh Bachchan gets Covid vaccine, says 'all family done except Abhishek'

Even Deadpool needs a COVID-19 jab. Actor Ryan Reynolds on Wednesday took a jab of the COVID-19 vaccine and shared a picture video of him getting the shot on his Instagram page.

Ryan Reynolds receives COVID-19 vaccine shot

BioNTech-Pfizer said that their COVID-19 vaccine showed 100 per cent efficacy against the coronavirus in 12 to 15-year-olds, this comes as the pharma company eye approval for the adolescents to get the jabs before the next school year.

BioNtech-Pfizer say COVID-19 jab 100% effective on 12-15 year olds

Pfizer-BioNTech on Thursday claimed their coronavirus vaccine offers protection at least six months after the second dose and is fully effective against the South African variant that has caused concerns worldwide.

Pfizer says Covid-19 vaccine offers protection for at least six months, effective against South African variant

The European Union drug regulator said on Wednesday that it has not identified any "specific risk factors" of the Oxford-AstraZeneca coronavirus vaccine, but is carrying out further analysis.

EU says no age-related risk of AstraZeneca vaccine found so far

BioNTECh-Pfizer claimed on Wednesday that their coronavirus vaccine has an efficacy of 100 per cent in the 12 to 15-year-old age group. Phase 3 trials conducted on 2,260 adolescents in the US showed "100 per cent efficacy and robust antibody responses", the pharma giants said in a statement.

BioNTech-Pfizer say their Covid-19 vaccine has 100% efficacy in 12-15 year olds

Germany is suspending routine use of the Oxford-AstraZeneca COVID-19 vaccine for people aged below 60 because of a risk of rare blood clots. The decision was taken by the country's health minister after an emergency meeting.

Germany halts use of AstraZeneca COVID-19 vaccine for under-60s